FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between DMR SME IPO and Nidan Laboratories and Healthcare IPO.
DMR SME IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Nidan Laboratories and Healthcare IPO is a SME Fixed Price Issue proposed to list at NSE SME.
DMR SME IPO | Nidan Laboratories and Healthcare IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | BSE SME | NSE SME |
Lead Managers | Shreni Shares Limited | First Overseas Capital Limited |
Registrar | Skyline Financial Services Private Ltd | Bigshare Services Pvt Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of DMR SME IPO is up to ₹2.09 Cr whereas the issue size of the Nidan Laboratories and Healthcare IPO is up to ₹50.00 Cr. The final issue price of DMR SME IPO is ₹21.00 per share and of Nidan Laboratories and Healthcare IPO is ₹125.00 per share.
DMR SME IPO | Nidan Laboratories and Healthcare IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹21.00 per share | ₹125.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 6000 shares | 1000 shares |
Fresh Issue Size | 7,98,000 shares | |
Fresh Issue Size (Amount) | up to ₹1.68 Cr | |
OFS Issue Size | 1,98,000 shares | |
OFS Issue Size (Amount) | up to ₹0.42 Cr | |
Issue Size Total | 9,96,000 shares | 40,00,000 shares |
Issue Size Total (Amount) | up to ₹2.09 Cr | up to ₹50.00 Cr |
DMR SME IPO opens on Nov 24, 2021, while Nidan Laboratories and Healthcare IPO opens on Oct 28, 2021. The closing date of DMR SME IPO and Nidan Laboratories and Healthcare IPO is Nov 29, 2021, and Nov 02, 2021, respectively.
DMR SME IPO | Nidan Laboratories and Healthcare IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Nov 24, 2021 | Oct 28, 2021 |
Issue Close | Nov 29, 2021 | Nov 02, 2021 |
Basis Of Allotment (Tentative) | Dec 02, 2021 | Nov 09, 2021 |
Initiation of Refunds (Tentative) | Dec 03, 2021 | Nov 10, 2021 |
Credit of Share (Tentative) | Dec 03, 2021 | Nov 11, 2021 |
Listing date (Tentative) | Dec 07, 2021 | Nov 12, 2021 |
Anchor Lockin End date 1 | Jan 01, 2022 | Dec 09, 2021 |
Anchor Lockin End date 2 | Mar 02, 2022 | Feb 07, 2022 |
DMR SME IPO P/E ratio is , as compared to Nidan Laboratories and Healthcare IPO P/E ratio of .
DMR SME IPO | Nidan Laboratories and Healthcare IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 98.97% | 99.99% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 72.46% | 71.22% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the DMR SME IPO retail investors (RII) are offered 4,74,000 shares while in Nidan Laboratories and Healthcare IPO retail investors are offered 4,74,000 shares. Qualified institutional buyers (QIB) are offered in DMR SME IPO and in Nidan Laboratories and Healthcare IPO.
DMR SME IPO | Nidan Laboratories and Healthcare IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 54,000 shares | 2,00,000 shares |
QIB | ||
NII | 4,68,000 shares | 19,00,000 shares |
RII | 4,74,000 shares | 19,00,000 shares |
Employee | ||
Others | ||
Total | 9,42,000 shares | 38,00,000 shares |
DMR SME IPO subscribed 11.43x in total, whereas Nidan Laboratories and Healthcare IPO subscribed 1.80x.
DMR SME IPO | Nidan Laboratories and Healthcare IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 8.53x | 0.15x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 14.29x | 3.44x |
Employee (times) | ||
Other (times) | ||
Total (times) | 11.43x | 1.80x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|